Clinical efficacy of vitamin-mineral complexes in the treatment of diseases of the gastrointestinal tract

Introduction. Chronic diseases of the digestive system lead to impaired absorption, assimilation and metabolism of macro- and micronutrients, primarily vitamins, inhibition of microflora, producing a number of vitamins, which requires correction of nutritional status. Purpose of the study. To study the clinical efficacy of the “Gastrobin Forte” vitamin-mineral complex in patients with gastritis and gastroduodenitis.

Materials and methods. An open observational clinical study was conducted on patients with chronic gastritis and gastroduodenitis (the main group - 60 patients) and a comparison group (30 patients). An objective examination of patients were evaluated before the study, on the 14th, 30th, 60th and 120th days of observation.

The results of the study. The 120-day administration of the vitamin-mineral complex «Gastrobin Forte» was well tolerated by patients, did not cause unwanted adverse reactions, including allergic ones. Two weeks later, there was a tendency to a decrease in the frequency of pain, discomfort in the epigastrium, and after 4 months all patients of the main group achieved persistent remission and the disappearance of the pain syndrome. At the same time, in the comparison group, complaints of discomfort in the epigastrium and unstable stool persisted in 10% of patients, and expressed pain syndrome persisted in 5% of patients. Conclusions. Gastrobin Forte is recommended as an additional source of vitamins and minerals for aftercare from hospital, as well as for prolonging remissions and preventing exacerbations.

1. Pogozheva A.V., Sorokina E.Y., Baturin A.K., Peskova E.V., Makurina O.N., Levin L.G. et aL. The deveLopment of diagnostics and aLimentary prevention system of non-communicabLe diseases. Al’manakh klinicheskoy medit-siny = Almanac of Clinical Medicine. 2015;1(1):67-74. (In Russ.) doi: 10.18786/2072-0505-2015-1-67-74.

2. Sugano K., Tack J., Kuipers EJ., Graham D.Y., EL-Omar E.M., Miura S. et aL. Kyoto gLobaL consensus report on HeLicobacter pyLori gastritis. Gut. 2015;64(9):1353-1367. doi: 10.1136/gutjnL-2015-309252.

3. Ivashkin V.T., Mayev I.V., Lapina T.L., SheptuLin A.A., Trukhmanov A.S., Baranskaya Y.K. et aL. Diagnostics and treatment of HeLicobacter pyLori infection in aduLts: CLinicaL guideLines of the Russian gastroenteroLogicaL association. Rossiyskiy zhurnal gastroehnterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55-70. (In Russ.) doi: 10.22416/1382-4376-2018-28-1-55-70.

4. Kon' I.Ya., ToboLeva M.A., KorosteLeva M.M. Vitamin deficiency: causes and ways of correction. Voprosy detskoy dietologii = Pediatric Nutrition. 2008;6(5):74-76. (In Russ.) AvaiLabLe at: http//www.phdynasty.ru/en/cataLog/ magazines/pediatric-nutrition/20082503/voLume-6-number-52505/21332.

5. Kodentsova V.M., Vrzhesinskaya O.A., Risnik D.V., Nikityuk D.B., TuteLyan V.A. Micronutrient status of popuLation of the Russian Federation and possibiLity of its correction. State of the probLem. Voprosypitaniya = Problems of Nutrition. 2017;86(4):113-124. (In Russ.) doi: 10.24411/0042-8833-2017-00067.

6. Masri O.A., ChaLhoub J.M., Sharara A.I. RoLe of vitamins in gastrointestinaL diseases. World J Gastroenterol. 2015;21(17):5191-5209. doi: 10.3748/wjg.v21.i17.5191.

7. Sipponen P, Maaroos H.I. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657-667. doi: 10.3109/00365521.2015.1019918.

8. Li Y., Xia R., Zhang B., Li Ch. Chronic Atrophic Gastritis: A Review. J Environ Pathol Toxicol Oncol. 2018;37(3):241-259. doi: 10.1615JEnvironPathoLToxicoLOncoL.2018026839.

9. Kang S.G., Wang C., Matsumoto S., Kim C.H. High and Low vitamin A therapies induce distinct FoxP3+ T-ceLL subsets and effectiveLy controL intestinaL infLammation. Gastroenterology. 2009;137(4):1391-1402. doi: 10.1053/j.gastro.2009.06.063.

10. Xu X., Yu E., Liu L., Zhang W., Wei X., Gao X., Song N., Fu C. Dietary intake of vitamins A, C, and E and the risk of coLorectaL adenoma: a meta-anaLysisof observationaL studies. Eur J Cancer Prev. 2013;22(6):529-539. doi: 10.1097/CEJ.0b013e328364f1eb.

11. Peres W.A., Chaves G.V., GonęaLves J.C., RamaLho A.. CoeLho H.S. Vitamin A deficiency in patients with hepatitis C virus-reLated chronic Liver disease. Br J Nutr. 2011;106(11):1724-1731. doi: 10.1017/S0007114511002145.

12. CLemente C., ELba S., Buongiorno G., BerLoco P., Guerra V., Di Leo A. Serum retinoL and risk of hepatoceLLuLar carcinoma in patients with chiLd-Pugh cLass A cirrhosis. Cancer Lett. 2002;178(2):123-129. doi: 10.1016/s0304-3835(01)00843-6.

13. Hamamoto S., Fukuda R., Ishimura N., Rumi M.A., Kazumori H., Uchida Y. et aL. 9-cis retinoic acid enhances the antiviraL effect of interferon on hepatitis C virus repLication through increased expression of type I interferon receptor. J Lab Clin Med. 2003;141(1):58-66. doi: 10.1067/mLc.2003.8.

14. Mirbagheri S.A., Nezami B.G., Assa S., Hajimahmoodi M. RectaL administration of d-aLpha tocopheroL for active uLcerative coLitis: a preLiminary report. World J Gastroenterol. 2008;14(39):5990-5995. doi: 10.3748/wjg.14.5990.

15. Adams L.A., Sanderson S., Lindor K.D., AnguLo P. The histoLogicaL course of nonaLcohoLic fatty Liver disease: a LongitudinaL study of 103 patients with sequentiaL Liver biopsies. J Hepatol. 2005;42(1):132-138. doi: 10.1016/j.jhep.2004.09.012.

16. Erhardt A., StahL W., Sies H., Lirussi F., Donner A., Haussinger D. PLasma LeveLs of vitamin E and carotenoids are decreased in patients with NonaLcohoLic Steatohepatitis (NASH). Eur J Med Res. 2011;16(2):76-78. doi: 10.1186/2047-783X-16-2-76.

17. Lavine J.E. Vitamin E treatment of nonaLcohoLic steatohepatitis in chiLdren: a piLot study. J Pediatr. 2000;136(6):734-738. AvaiLabLe at: https://www.ncbi.nLm.nih.gov/pubmed/10839868.

18. Hossein-Nezhad A., HoLick M.F. Vitamin D for heaLth: a gLobaL perspective. Mayo Clin Proc. 2013;88(7):720-755. doi: 10.1016/j.mayocp.2013.05.011.

19. PiLat T.L., Lashina E.L., KoLyaskina M.M., Bezrukavnikova L.M., KorosteLeva M.M., Gurevich K.G. et aL. The effectiveness of speciaLized diet therapy in patients with diseases of the gastrointestinaL tract. Terapiya = Therapy 2020;6(1):141-149. (In Russ.) doi: 10.18565/therapy.2020.1.141-149.

20. PiLat T.L., Ivanov A.A. BioLogicaLLy active food additives (theory, production, use). Moscow: AvvaLon, 2002; 710 p. (In Russ.) AvaiLabLe at: https//search. rsL.ru/ru/record/01000968879.